Pharmaceutical composition for treating rheumatoid arthritis and chronic infectious arthritis

Abstract

The invention discloses a pharmaceutical composition for treating rheumatoid arthritis and chronic infectious arthritis. The pharmaceutical composition is prepared from 26 raw-material medicines such as acacia catechu, rhizoma sparganii, rhizoma gastrodiae, akebiaquinata, erycibe obtusifolia benth, murraya paniculata, vietnamese sophora roots, lalang grass rhizomes, verbena, rhizoma arisaematis, radix geutianae, bombyx batryticatus, prepared rehmannia roots, centipedes, curcuma zedoary, fineleaf schizonepeta herbs, radix rubiae and trogopterus dung. Conventional auxiliary materials are added into the pharmaceutical composition with the conventional technology, the product is prepared into a clinical-acceptant capsule or a clinical-acceptant tablet or a clinical-acceptant granule or a clinical-acceptant pill or clinical-acceptant oral liquid or a clinical-acceptant emplastrum or a clinical-acceptant spraying agent or a clinical-acceptant ointment or a clinical-acceptant liniment or a clinical-acceptant tincture, and the pharmaceutical composition has the effects of warming and activating meridians, activating blood, removing stasis, relieving swelling and pain, dispelling wind and eliminating dampness, has the good treating effects on treating rheumatoid arthritis and chronic infectious arthritis, and is free of toxic and side effects.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating rheumatic rheumatoid arthritis. Background technique [0002] Rheumatism is a clinically common disease, frequently-occurring disease, long onset period, diverse clinical symptoms, and long treatment period. Because the etiology and pathogenesis of such diseases are relatively complicated, and the clinical manifestations are mostly borderline and multidisciplinary, coupled with the limitations of traditional Chinese medicine itself and the inconsistency of understanding of such diseases, clinical dialectical treatment and treatment of such diseases should be given. The clinical research work of similar lesions brings certain difficulties. In Chinese medicine, rheumatism is collectively referred to as "arthritis". The forty-third article on numbness in "Huangdi Neijing Suwen" says: "The three qis of wind, cold, and damp are mixed together,...

AI Technical Summary

Problems solved by technology

Because the etiology and pathogenesis of such diseases are relatively complicated, and the clinical manifestations are mostly borderline and multidisciplinary, coupled with the limitations of traditional Chinese medicine itself and the inconsistency of understanding of such diseases, clinical dialectical treatment and treatment of such diseases should be given. The clinical research work of similar lesions brings certain difficulties

Images